Ambev (ABEV) Cash & Equivalents (2011 - 2025)

Ambev has reported Cash & Equivalents for 15 years, with the latest figure at $3.5 billion in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 29.74% year-over-year to $3.5 billion; the trailing twelve-month figure through Dec 2025 stood at $3.5 billion (down 29.74% YoY), and the FY2025 full-year result was $3.5 billion, down 29.74% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $3.5 billion, up from $3.4 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $4.9 billion in Q4 2024, with the low at $2.4 billion in Q1 2023.
• Historically, Cash & Equivalents has averaged $3.2 billion across 5 years, with a median of $3.1 billion in 2024.
• Annual changes were most pronounced in 2024 — Cash & Equivalents soared 51.69% — and 2025, when it dropped 29.74%.
• Ambev's Cash & Equivalents stood at $3.0 billion in 2021, then declined by 5.12% to $2.8 billion in 2022, then increased by 14.9% to $3.2 billion in 2023, then surged by 51.69% to $4.9 billion in 2024, then retreated by 29.74% to $3.5 billion in 2025.
• The last three Cash & Equivalents figures came in at $3.5 billion (Q4 2025), $3.4 billion (Q3 2025), and $2.9 billion (Q2 2025), per Business Quant data.